Literature DB >> 1182629

Prevalence of hepatitis B antibodies in hospital personnel.

W D Leers, G M Kouroupis.   

Abstract

Of 426 hospital staff tested for hepatitis B surface antibody (anti-HBS) by the radioimmunoassay method 57 (13.4%) had positive results. Laboratory staff had the highest prevalence, followed by nurses, and both values were significantly higher than that of administrative staff. Clerical staff working in laboratories were at the same risk for hepatitis B as general-duty nurses. Significantly more staff with anti-HBS had a history of hepatitis (19.3%) compared with staff without anti-HBS (79%), and significantly more staff with a history of hepatitis had anti-HBS (25.6%) compared with staff without such a history (12.0%). History of blood transfusions was not related to prevalence of anti-HBS. The risk for hepatitis B is greater in hospital staff who are in direct contact with patients or handle patients' blood and other specimens. However, contact with patients is less important than contact with patients' blood and other specimens.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1182629      PMCID: PMC1956678     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  10 in total

1.  Hepatitis B infection. A point-prevalence study in 15 US hemodialysis centers.

Authors:  W Szmuness; A M Prince; G F Grady; M K Mann; R W Levine; E A Friedman; M J Jacobs; A Josephson; S Ribot; F L Shapiro; K H Stenzel; W N Suki; G Vyas
Journal:  JAMA       Date:  1974-02-25       Impact factor: 56.272

2.  Acquisition of antibody to hepatitis B antigen in three socioeconomically different medical populations.

Authors:  C E Cherubin; R H Purcell; J J Lander; T G McGinn; L A Cone
Journal:  Lancet       Date:  1972-07-22       Impact factor: 79.321

3.  A comparison of the frequency of hepatitis-B antigen and antibody in hospital and nonhospital personnel.

Authors:  T L Lewis; H J Alter; T C Chalmers; P V Holland; R H Purcell; D W Alling; D Young; L D Frenkel; S L Lee; M E Lamson
Journal:  N Engl J Med       Date:  1973-09-27       Impact factor: 91.245

4.  Assay of Australia antigen and antibody employing double-antibody and solid-phase radioimmunoassay techniques and comparison with the passive hemagglutination methods.

Authors:  F B Hollinger; V Vorndam; G R Dreesman
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

5.  Frequency of antibody to hepatitis-associated antigen as measured by a new radioimmunoassay technique.

Authors:  J J Lander; H J Alter; R H Purcell
Journal:  J Immunol       Date:  1971-05       Impact factor: 5.422

6.  Detection of Australia antigen and antibody by means of radioimmunoassay techniques.

Authors:  J H Walsh; R Yalow; S A Berson
Journal:  J Infect Dis       Date:  1970-05       Impact factor: 5.226

7.  Hemagglutination assay for antigen and antibody associated with viral hepatitis.

Authors:  G N Vyas; N R Shulman
Journal:  Science       Date:  1970-10-16       Impact factor: 47.728

8.  Immune response to hepatitis B surface antigen.

Authors:  A B Ibrahim; G N Vyas; H A Perkins
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

9.  Hepatitis B antigen in screened blood units for transfusion in renal dialysis patients.

Authors:  W D Leers; G M Kouroupis
Journal:  Can Med Assoc J       Date:  1974-02-02       Impact factor: 8.262

10.  Occurrence of hepatitis and hepatitis B surface antigen in adult patients with acute leukemia.

Authors:  D H Cowan; G M Kouroupis; W D Leers
Journal:  Can Med Assoc J       Date:  1975-03-22       Impact factor: 8.262

  10 in total
  4 in total

1.  Prevalence of hepatitis B surface antibodies in ethnic groups of a Canadian hospital staff population.

Authors:  W D Leers
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

2.  Hepatitis in clinical laboratories 1973-74.

Authors:  N R Grist
Journal:  J Clin Pathol       Date:  1976-06       Impact factor: 3.411

3.  High risk groups for hepatitis B virus infection in a university hospital staff as determined by detection of HB antigens, antibodies, and Dane particles.

Authors:  N Scheiermann; E K Kuwert; E Pieringer; R Dermietzel
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

4.  Hepatitis B virus antibody prevalence in anaesthetists.

Authors:  M A Chernesky; R A Browne; P Rondi
Journal:  Can Anaesth Soc J       Date:  1984-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.